Research Highlights: A recently published SeroNet protocol paper, led by Todd Lucas, Ph.D., C.S. Mott Endowed Professor at Michigan State University, Department of Public Health, and co-authored by the Salimetrics scientific team—founder Douglas Granger and CSO Steve Granger, underscores the power of saliva-based antibody testing during the COVID-19 pandemic. Conducted in Flint, Michigan, this randomized control trial leveraged convenient, non-invasive saliva collection to measure SARS-CoV-2 antibodies—demonstrating how salivary testing can boost testing uptake and provide critical insights into infection and immunity. While the study also explored culturally tailored messaging to address disparities in testing within underserved communities, its broader finding reinforces saliva as an accessible and reliable matrix for immunological research and public health surveillance.